Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVP-1203 in Acute Low Back Pain
NCT04082975Phase 3Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Jan 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aceclofenac and eperisone in acute low back pain (2 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoint: Change from baseline in pain intensity assessed by Visual Analogue Scale at Day 7. Started Jan 2020; status: completed.
02
Drugs
aceclofenaceperisone
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT04082975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04082975.